PHARMING GROUP - stock earnings
PHARM.AS Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| Aug. 1, 2024 AfterMarket | - / - | 62.0 million | - / 64.1 million | 66.2 million |
PHARM.AS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -2.8 million EUR | 73.5 million EUR |
| 2023Q3 | 3.3 million EUR | 63.0 million EUR |
| 2023Q2 | 1.2 million EUR | 50.5 million EUR |
| 2023Q1 | -11.2 million EUR | 39.0 million EUR |
| 2022Q4 | -13.6 million EUR | 50.9 million EUR |
| 2022Q3 | 9.3 million EUR | 55.3 million EUR |
| 2022Q2 | 15.1 million EUR | 48.0 million EUR |
| 2022Q1 | 3.1 million EUR | 41.8 million EUR |
| 2021Q4 | 1.6 million EUR | 40.2 million EUR |
| 2021Q3 | -581850 EUR | 42.7 million EUR |
| 2021Q2 | 5.0 million EUR | 41.9 million EUR |
| 2021Q1 | 7.0 million EUR | 36.0 million EUR |
| 2020Q4 | 8.7 million EUR | 57.7 million EUR |
| 2020Q3 | 8.2 million EUR | 49.9 million EUR |
| 2020Q2 | 9.9 million EUR | 40.3 million EUR |
| 2020Q1 | 8.4 million EUR | 49.3 million EUR |
| 2019Q4 | 12.7 million EUR | 48.5 million EUR |
| 2019Q3 | 9.9 million EUR | 42.4 million EUR |
| 2019Q2 | 6.9 million EUR | 43.1 million EUR |
| 2019Q1 | 6.7 million EUR | 35.2 million EUR |
| 2018Q4 | 13.1 million EUR | 35.3 million EUR |
| 2018Q3 | 5.4 million EUR | 39.1 million EUR |
| 2018Q2 | 2.8 million EUR | 28.0 million EUR |
| 2018Q1 | 3.3 million EUR | 29.5 million EUR |
| 2017Q4 | -43.2 million EUR | 34.3 million EUR |
| 2017Q3 | -8.2 million EUR | 26.8 million EUR |
| 2017Q2 | -24.8 million EUR | 16.2 million EUR |
| 2017Q1 | -5.7 million EUR | 15.5 million EUR |
| 2016Q4 | -6.4 million EUR | 6.6 million EUR |
| 2016Q3 | -3.8 million EUR | 3.5 million EUR |
| 2016Q2 | -3.3 million EUR | 3.0 million EUR |
| 2016Q1 | -3.4 million EUR | 2.2 million EUR |
| 2015Q4 | -3.9 million EUR | 2.1 million EUR |
| 2015Q3 | -2.4 million EUR | 3.3 million EUR |
| 2015Q2 | -2.2 million EUR | 3.5 million EUR |
| 2015Q1 | -1.3 million EUR | 1.8 million EUR |
| 2014Q4 | 13.9 million EUR | 17.2 million EUR |
| 2014Q3 | 2.8 million EUR | 1.1 million EUR |
| 2014Q2 | -4.0 million EUR | 1.1 million EUR |
| 2014Q1 | -16.0 million EUR | 1.4 million EUR |
| 2013Q4 | -4.2 million EUR | 1.0 million EUR |
| 2013Q3 | -4.1 million EUR | 1.2 million EUR |
| 2013Q2 | -1.9 million EUR | 4.4 million EUR |
| 2013Q1 | -5.4 million EUR | 483625 EUR |
| 2012Q4 | -617465 EUR | 8.5 million EUR |
| 2012Q3 | -7.8 million EUR | 505899 EUR |
| 2012Q2 | -9.9 million EUR | 855646 EUR |
| 2012Q1 | -6.5 million EUR | 879708 EUR |
| 2011Q4 | -3.1 million EUR | 748388 EUR |
| 2011Q3 | -4.8 million EUR | 750354 EUR |
| 2011Q2 | -4.5 million EUR | 690628 EUR |
| 2011Q1 | -3.6 million EUR | 635914 EUR |
| 2010Q4 | -20.9 million EUR | -113533 EUR |
| 2010Q3 | -6.6 million EUR | 265001 EUR |
| 2010Q2 | -19.4 million EUR | 176287 EUR |
| 2010Q1 | -7.7 million EUR | 205725 EUR |
| 2009Q4 | -8.4 million EUR | 553308 EUR |
| 2009Q3 | -8.0 million EUR | 182855 EUR |
| 2009Q2 | -9.2 million EUR | 249494 EUR |
| 2009Q1 | -6.2 million EUR | 104157 EUR |
PHARM.AS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -8.8 million EUR | 205.3 million EUR |
| 2022 | 12.7 million EUR | 191.6 million EUR |
| 2021 | 14.1 million EUR | 166.9 million EUR |
| 2020 | 31.0 million EUR | 187.5 million EUR |
| 2019 | 36.2 million EUR | 169.0 million EUR |
| 2018 | 25.0 million EUR | 135.1 million EUR |
| 2017 | -80.3 million EUR | 90.0 million EUR |
| 2016 | -17.5 million EUR | 15.9 million EUR |
| 2015 | -10.0 million EUR | 10.8 million EUR |
| 2014 | -5.8 million EUR | 21.2 million EUR |
| 2013 | -15.1 million EUR | 6.8 million EUR |
| 2012 | -24.2 million EUR | 10.6 million EUR |
| 2011 | -17.1 million EUR | 3.0 million EUR |
| 2010 | -56.4 million EUR | 572941 EUR |
| 2009 | -32.1 million EUR | 1.1 million EUR |
| 2008 | -26.2 million EUR | 663271 EUR |
| 2007 | -35.6 million EUR | 689009 EUR |
| 2006 | -18.5 million EUR | 147000 EUR |
| 2005 | -17.9 million EUR | 405102 EUR |
PHARM.AS
Price: €0.83
52 week price:
Earnings Per Share: -0.01 EUR
P/E Ratio: -35.27
Exchange: AMS
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 572.4 million